Filing Details
- Accession Number:
- 0001209191-20-013032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-26 16:35:25
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-26 16:35:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-24 | 2,416 | $239.23 | 29,866 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-25 | 938 | $230.07 | 28,928 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 330 | $231.62 | 28,598 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 320 | $232.89 | 28,278 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 640 | $234.77 | 27,638 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 320 | $236.26 | 27,318 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 480 | $238.30 | 26,838 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $230.07 (range $229.75 to $230.57).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $231.62 (range $231.12 to $232.06).
- Open market sales reported on this line occurred at a weighted average price of $232.89 (range $232.73 to $233.05).
- Open market sales reported on this line occurred at a weighted average price of $234.77 (range $234.51 to $235.46).
- Open market sales reported on this line occurred at a weighted average price of $236.26 (range $235.72 to $236.80).
- Open market sales reported on this line occurred at a weighted average price of $238.30 (range $238.16 to $238.54).
Billionaire Hedge Funds
